Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
This overview highlights the metrics that distinguish index and mutual funds, including costs, risk, and historical performance for informed choices.
24,764 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
As mortgage markets tighten and churn rises, lenders are turning to mentorship to convert recruits into steady, produ...
States are unlocking church land for housing through by-right rules, aiming to speed up construction and boost afford...
BNB slips on a brief pullback, but longer-term momentum remains constructive as rising moving averages and a quiet re...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...
Oil markets moved higher for the week as geopolitical risk and supply worries outweighed new data. u.s. prices turn h...
GameStop's latest SEC filing confirms it still holds 4,710 BTC, ending weeks of speculation over on-chain moves. The ...
Finance of America reported a profitable first quarter, reversing Q4 losses as originations climbed and portfolio gai...
A standout AI infrastructure stock is delivering blistering earnings growth in 2026, reshaping the investing landscap...
AI demand is broadening from chipmakers to the hardware backbone that powers deployments, a shift that could lift inf...
BlackRock’s entry into XRP exposure signals a broader institutional push, with XRP hovering around $1.41 as regulator...
AI-driven payroll reductions accelerate as major firms trim jobs, altering earnings and market sentiment in May 2026.